Biomerica is a global biomedical technology company that develops, manufactures, and markets diagnostic test kits and therapeutic products. Its products analyze blood, urine, nasal, or fecal samples to diagnose diseases, food intolerances, and other conditions. Key products include inFoods IBS, a diagnostic-guided therapy using a blood test to identify IBS-triggering foods, and hp+detect, an FDA-cleared test for detecting Helicobacter pylori. Products are sold worldwide to clinical laboratories and point-of-care settings.
Q2 FY2026 — expected 2026-09-23
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-08-29 | 2025-05-31 | 0001641172-25-026041 | EDGAR | 38K words |
| 2024-08-28 | 2024-05-31 | 0001493152-24-034208 | EDGAR | — |
| 2023-08-25 | 2023-05-31 | 0001493152-23-030254 | EDGAR | — |
| 2022-08-29 | 2022-05-31 | 0001513162-22-000114 | EDGAR | — |
| 2021-08-27 | 2021-05-31 | 0001513162-21-000112 | EDGAR | — |
| 2020-08-31 | 2020-05-31 | 0001513162-20-000185 | EDGAR | — |
| 2019-08-29 | 2019-05-31 | 0001513162-19-000194 | EDGAR | — |
| 2018-08-29 | 2018-05-31 | 0001513162-18-000223 | EDGAR | — |
| 2017-08-29 | 2017-05-31 | 0001513162-17-000246 | EDGAR | — |
| 2016-08-29 | 2016-05-31 | 0001513162-16-000987 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-01-14 | 2025-11-30 | 0001493152-26-002286 | EDGAR | 18K words |
| 2025-10-14 | 2025-08-31 | 0001493152-25-018043 | EDGAR | — |
| 2025-04-14 | 2025-02-28 | 0001641172-25-004571 | EDGAR | — |
| 2025-01-14 | 2024-11-30 | 0001493152-25-002209 | EDGAR | — |
| 2024-10-15 | 2024-08-31 | 0001493152-24-041156 | EDGAR | — |
| 2024-04-12 | 2024-02-29 | 0001493152-24-014474 | EDGAR | — |
| 2024-01-16 | 2023-11-30 | 0001493152-24-002331 | EDGAR | — |
| 2023-10-12 | 2023-08-31 | 0001493152-23-037070 | EDGAR | — |
| 2023-04-14 | 2023-02-28 | 0001513162-23-000067 | EDGAR | — |
| 2023-01-13 | 2022-11-30 | 0001513162-23-000005 | EDGAR | — |
| 2022-10-13 | 2022-08-31 | 0001513162-22-000122 | EDGAR | — |
| 2022-04-14 | 2022-02-28 | 0001513162-22-000051 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-12-16 | 0001493152-25-027891 | EDGAR | 1K words |
| 2025-10-08 | 0001493152-25-017363 | EDGAR | — |
| 2025-06-06 | 0001641172-25-013942 | EDGAR | — |
| 2025-04-16 | 0001641172-25-004976 | EDGAR | — |
| 2024-12-17 | 0001493152-24-050432 | EDGAR | — |
| 2024-11-06 | 0001493152-24-043867 | EDGAR | — |
| 2024-06-28 | 0001493152-24-025656 | EDGAR | — |
| 2024-05-10 | 0001493152-24-018697 | EDGAR | — |
| 2023-12-11 | 0001493152-23-044431 | EDGAR | — |
| 2023-09-19 | 0001493152-23-033030 | EDGAR | — |
193 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000073290 |
| Ticker | BMRA |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
| Headquarters | Irvine, California |
| Website | https://www.biomerica.com |
| Listed | 1978-09-26 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report